"リゲル" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonRigel Reports Second Quarter 2025 Financial Results and Provides Business Update - PR Newswire
Rigel Reports Second Quarter 2025 Financial Results and Provides Business Update PR Newswire
Rigel Pharmaceuticals' (NASDAQ:RIGL) Earnings Are Of Questionable Quality - Yahoo Finance
Rigel Pharmaceuticals' (NASDAQ:RIGL) Earnings Are Of Questionable Quality Yahoo Finance
Darrell Rigel, MD, MS, on Real-World Advancements in Actinic Keratosis Management - Dermatology T...
Darrell Rigel, MD, MS, on Real-World Advancements in Actinic Keratosis Management Dermatology Times
Rigel Pharmaceuticals at Cantor Conference: Strategic Growth and Expansion - Investing.com
Rigel Pharmaceuticals at Cantor Conference: Strategic Growth and Expansion Investing.com
Rigel Pharmaceuticals: Q2 Earnings Fuel A Potential Breakout - Seeking Alpha
Rigel Pharmaceuticals: Q2 Earnings Fuel A Potential Breakout Seeking Alpha
Rigel Pharmaceuticals (RIGL) Q2 Earnings and Revenues Surpass Estimates - Nasdaq
Rigel Pharmaceuticals (RIGL) Q2 Earnings and Revenues Surpass Estimates Nasdaq
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - PR...
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) PR Newswire
Rigel Pharmaceuticals, Inc. (RIGL) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
Rigel Pharmaceuticals, Inc. (RIGL) Hits Fresh High: Is There Still Room to Run? Yahoo Finance
Rigel Reports First Quarter 2025 Financial Results and Provides Business Update - PR Newswire
Rigel Reports First Quarter 2025 Financial Results and Provides Business Update PR Newswire
Results: Rigel Pharmaceuticals, Inc. Exceeded Expectations And The Consensus Has Updated Its Esti...
Results: Rigel Pharmaceuticals, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates Yahoo Finance
Rigel Pharmaceuticals, Inc. (RIGL) Soars to 52-Week High, Time to Cash Out? - Yahoo Finance
Rigel Pharmaceuticals, Inc. (RIGL) Soars to 52-Week High, Time to Cash Out? Yahoo Finance
Rigel Announces Poster Presentations at the 2025 ASCO Annual Meeting and EHA2025 Congress - PR Ne...
Rigel Announces Poster Presentations at the 2025 ASCO Annual Meeting and EHA2025 Congress PR Newswire
H.C. Wainwright Reiterates a Buy Rating on Rigel Pharmaceuticals (RIGL), Sets a $57 PT - Yahoo Fi...
H.C. Wainwright Reiterates a Buy Rating on Rigel Pharmaceuticals (RIGL), Sets a $57 PT Yahoo Finance
Rigel Pharmaceuticals Inc (RIGL) Q2 2025 Earnings Call Highlights: Record Revenue and Raised ... ...
Rigel Pharmaceuticals Inc (RIGL) Q2 2025 Earnings Call Highlights: Record Revenue and Raised ... Yahoo Finance
Rigel Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - ...
Rigel Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update PR Newswire
Can Rigel (RIGL) Climb 69.55% to Reach the Level Wall Street Analysts Expect? - Yahoo Finance
Can Rigel (RIGL) Climb 69.55% to Reach the Level Wall Street Analysts Expect? Yahoo Finance
Rigel Provides Business Update and 2025 Outlook - PR Newswire
Rigel Provides Business Update and 2025 Outlook PR Newswire
Is Rigel Pharmaceuticals (RIGL) Stock Undervalued Right Now? - Yahoo Finance
Is Rigel Pharmaceuticals (RIGL) Stock Undervalued Right Now? Yahoo Finance
Rigel Pharmaceuticals Inc (RIGL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... ...
Rigel Pharmaceuticals Inc (RIGL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... Yahoo Finance
Blue-white Rigel is Orion’s brightest star - EarthSky
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS - PR Newswire
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS PR Newswire
Here's Why Rigel (RIGL) Is a Great 'Buy the Bottom' Stock Now - Yahoo Finance
Here's Why Rigel (RIGL) Is a Great 'Buy the Bottom' Stock Now Yahoo Finance
Rigel Announces Conference Call and Webcast to Report Second Quarter 2025 Financial Results and B...
Wall Street Analysts See a 71.97% Upside in Rigel (RIGL): Can the Stock Really Move This High? - ...
Wall Street Analysts See a 71.97% Upside in Rigel (RIGL): Can the Stock Really Move This High? Yahoo Finance
Rigel Pharmaceuticals Receives IBD Stock Rating Upgrade - Investor's Business Daily
Rigel Pharmaceuticals Receives IBD Stock Rating Upgrade Investor's Business Daily
Rigel Highlights Initial Data from Ongoing Phase 1b Study Evaluating R289 in LR-MDS at the 66th A...
Rigel Pharmaceuticals (RIGL) Beats Q1 Earnings and Revenue Estimates - Nasdaq
Rigel Pharmaceuticals (RIGL) Beats Q1 Earnings and Revenue Estimates Nasdaq
Bristol-Myers Squibb expands immuno-oncology pipeline with Flexus Biosciences, Rigel Pharmaceutic...
Bristol-Myers Squibb expands immuno-oncology pipeline with Flexus Biosciences, Rigel Pharmaceuticals deals FirstWord Pharma
Travelmarvel Rigel Ship Review - Cruise Critic
Travelmarvel Rigel Ship Review Cruise Critic
Rigel Announces R289 Granted Orphan Drug Designation by the FDA for MDS - PR Newswire
Rigel Announces R289 Granted Orphan Drug Designation by the FDA for MDS PR Newswire
Olga Rigel Obituary - Apex, NC - Dignity Memorial
Olga Rigel Obituary - Apex, NC Dignity Memorial
With 57% ownership of the shares, Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) is heavily dominated ...
With 57% ownership of the shares, Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) is heavily dominated by institutional owners Yahoo Finance
Rigel Pharmaceuticals’ Earnings Call Highlights Robust Growth - TipRanks
Rigel Pharmaceuticals’ Earnings Call Highlights Robust Growth TipRanks
Rigel Pharmaceuticals Reports Strong Q2 2025 Results - TipRanks
Rigel Pharmaceuticals Reports Strong Q2 2025 Results TipRanks
Rigel Pharmaceuticals: Q1 Earnings Showcase Growing Momentum (NASDAQ:RIGL) - Seeking Alpha
Rigel Pharmaceuticals: Q1 Earnings Showcase Growing Momentum (NASDAQ:RIGL) Seeking Alpha
Rigel Pharmaceuticals: 3-Drug Company Reaches Profitability (RIGL) - Seeking Alpha
Rigel Pharmaceuticals: 3-Drug Company Reaches Profitability (RIGL) Seeking Alpha
Rigel Pharmaceuticals, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Pr...
Rigel Pharmaceuticals, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions simplywall.st
Institutional investors have a lot riding on Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) with 65% o...
Institutional investors have a lot riding on Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) with 65% ownership simplywall.st
Alfonzo Rigel Obituary (2025) - Durham, NC - American Cremation & Funeral Service - Legacy.com
Alfonzo Rigel Obituary (2025) - Durham, NC - American Cremation & Funeral Service Legacy.com
Maria Rigel • Director of Thus Spoke the Wind - Cineuropa
Biotech Leader Rigel Pharmaceuticals Announces Packed September Schedule with 4 Major Healthcare ...
Biotech Leader Rigel Pharmaceuticals Announces Packed September Schedule with 4 Major Healthcare Conferences Stock Titan
Rigel Pharmaceuticals’ SWOT analysis: promising pipeline drives stock potential - Investing.com
Rigel Pharmaceuticals’ SWOT analysis: promising pipeline drives stock potential Investing.com
Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) CEO Compensation Looks Acceptable To Us And Here's Wh...
Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) CEO Compensation Looks Acceptable To Us And Here's Why simplywall.st
Rigel Pharma’s Comeback: Profits, Pipeline Progress, And A Bargain Price - Finimize
Rigel Pharma’s Comeback: Profits, Pipeline Progress, And A Bargain Price Finimize
Rigel Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary - Trad...
Rigel Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary TradingView
Biotech Rigel Pharmaceuticals Reveals Q2 2025 Earnings Date: Key Financial Results Coming August ...
Biotech Rigel Pharmaceuticals Reveals Q2 2025 Earnings Date: Key Financial Results Coming August 5 Stock Titan
Review: Moon Rigel Max - road.cc
Review: Moon Rigel Max road.cc
Rigel Reports Third Quarter 2024 Financial Results and Provides Business Update - PR Newswire
Rigel Reports Third Quarter 2024 Financial Results and Provides Business Update PR Newswire
Eli Lilly and Rigel Pharmaceuticals Advance Rheumatoid Arthritis Study with LY3871801 - TipRanks
Eli Lilly and Rigel Pharmaceuticals Advance Rheumatoid Arthritis Study with LY3871801 TipRanks
Eli Lilly and Rigel’s Promising Study on Rheumatoid Arthritis Treatment - TipRanks
Eli Lilly and Rigel’s Promising Study on Rheumatoid Arthritis Treatment TipRanks
Rigel Pharmaceuticals: Realizing The Promise Of Its Acquired Pipeline Agents (NASDAQ:RIGL) - Seek...
Rigel Pharmaceuticals: Realizing The Promise Of Its Acquired Pipeline Agents (NASDAQ:RIGL) Seeking Alpha
Travelmarvel's 2026 Europe features new river vessel, Rigel - Seatrade Cruise News
Travelmarvel's 2026 Europe features new river vessel, Rigel Seatrade Cruise News
John Rigel Obituary - Medford, OR - Dignity Memorial
John Rigel Obituary - Medford, OR Dignity Memorial
TEDx Kings Park Youth Speaker: Rigel Paciente - Scitech
The Forgotten Tragedy of the MS Rigel - Life in Norway
The Forgotten Tragedy of the MS Rigel Life in Norway
Review: Moon Rigel Pro 1000lm - road.cc
Review: Moon Rigel Pro 1000lm road.cc
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Shares Could Be 36% Below Their Intrinsic Value Estimat...
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Shares Could Be 36% Below Their Intrinsic Value Estimate simplywall.st
Help from Orion - NASA Science (.gov)
Help from Orion NASA Science (.gov)
SEC gives thumbs up to Aurous combination with Rigel - Miningmx
SEC gives thumbs up to Aurous combination with Rigel Miningmx
Ella Rigel - Track & Field, Cross Country - Miami University RedHawks
Ella Rigel - Track & Field, Cross Country Miami University RedHawks
Indonesia air tech startup Nafas raises funding from Rigel Capital, QDB - DealStreetAsia
Indonesia air tech startup Nafas raises funding from Rigel Capital, QDB DealStreetAsia
Rigel Announces Availability of REZLIDHIA™ (olutasidenib) in the U.S. for the Treatment of Adult ...
Rigel Pharmaceuticals Acquires U.S. Rights to GAVRETO® - PR Newswire
Rigel Pharmaceuticals Acquires U.S. Rights to GAVRETO® PR Newswire
MD Anderson and Rigel collaborate to advance olutasidenib in AML - MD Anderson Cancer Center
MD Anderson and Rigel collaborate to advance olutasidenib in AML MD Anderson Cancer Center
Rigel Pharma Remains Bullish, Growth Fueled By FDA-Approved Drugs, Strategic Partnerships - Seeki...
Rigel Pharma Remains Bullish, Growth Fueled By FDA-Approved Drugs, Strategic Partnerships Seeking Alpha
Witch Head Nebula is perfect on October nights - EarthSky
Rigel Announces Reverse Stock Split - PR Newswire
Rigel Announces Reverse Stock Split PR Newswire
Rigel Expands Relationship with Kissei to include REZLIDHIA® (olutasidenib) in Japan, the Republi...
Berkeley Councilmember Rigel Robinson to step down, end run for mayor, citing 'harassment, stalki...
Berkeley Councilmember Rigel Robinson to step down, end run for mayor, citing 'harassment, stalking and threats' Berkeleyside
Rigel to Present at the 2024 Cantor Global Healthcare Conference - PR Newswire
Rigel to Present at the 2024 Cantor Global Healthcare Conference PR Newswire
Rigel Technology (S) Pte Ltd - MOE
Rigel Pharmaceuticals Provides Business Update - PR Newswire
Rigel Pharmaceuticals Provides Business Update PR Newswire
Obituary for Cynthia S. Rigel - Hanneman Family Funeral Homes & Crematory
Obituary for Cynthia S. Rigel Hanneman Family Funeral Homes & Crematory
Lilly and Rigel Enter Strategic Collaboration to Develop RIPK1 Inhibitors for the Potential Treat...
Lilly and Rigel Enter Strategic Collaboration to Develop RIPK1 Inhibitors for the Potential Treatment of Immunological and Neurodegenerative Diseases Eli Lilly and Company
Rigel Pharmaceuticals Completes Transfer of GAVRETO® (pralsetinib) New Drug Application - PR News...
Rigel Pharmaceuticals Completes Transfer of GAVRETO® (pralsetinib) New Drug Application PR Newswire
2022 January 24 - Rigel and the Witch Head Nebula - NASA (.gov)
2022 January 24 - Rigel and the Witch Head Nebula NASA (.gov)
Rigel wins US approval of rival drug to Servier leukemia treatment - BioPharma Dive
Rigel wins US approval of rival drug to Servier leukemia treatment BioPharma Dive
Rigel Announces Publication of REZLIDHIA™ (olutasidenib) Phase 2 Clinical Results in Blood Advanc...
Rigel Announces Publication of REZLIDHIA™ (olutasidenib) Phase 2 Clinical Results in Blood Advances PR Newswire
Rigel Cabinetry launches digital catalog - LBM Journal
Rigel Cabinetry launches digital catalog LBM Journal
After Roche breakup, Blueprint Medicines finds Gavreto a new home at Rigel - Fierce Pharma
After Roche breakup, Blueprint Medicines finds Gavreto a new home at Rigel Fierce Pharma
Rigel Secures Credit Facility for Up to $60 Million - PR Newswire
Rigel Secures Credit Facility for Up to $60 Million PR Newswire
Rigel scores green light in AML just 4 months after buying asset from Forma - Fierce Pharma
Rigel scores green light in AML just 4 months after buying asset from Forma Fierce Pharma
Rigel bets $230M that Forma's leukemia drug gets in formation with FDA - Fierce Biotech
Rigel bets $230M that Forma's leukemia drug gets in formation with FDA Fierce Biotech
Strange New Worlds - Rigel VII - StarTrek.com
Strange New Worlds - Rigel VII StarTrek.com
Blueprint’s Cancer Drug Gavreto Finds New Home at Rigel after Roche Split - BioSpace
Blueprint’s Cancer Drug Gavreto Finds New Home at Rigel after Roche Split BioSpace
A guide to star Rigel - BBC Sky at Night Magazine
A guide to star Rigel BBC Sky at Night Magazine
CD Review | Rigel : Le souffle de la Révolution — Arion Baroque Orchestra - myscena.org
CD Review | Rigel : Le souffle de la Révolution — Arion Baroque Orchestra myscena.org
City Councilmember and mayoral candidate Rigel Robinson resigns, ends mayoral campaign - dailycal...
City Councilmember and mayoral candidate Rigel Robinson resigns, ends mayoral campaign dailycal.org
Rigel: Orion's Brightest Star - Space
OSP says Selma warrant detectives found Jesse Rigel, drugs and guns - KDRV
OSP says Selma warrant detectives found Jesse Rigel, drugs and guns KDRV
Eli Lilly hands over $125M to Rigel with $835M in biobucks for RIPK1 inhibitors - Fierce Biotech
Eli Lilly hands over $125M to Rigel with $835M in biobucks for RIPK1 inhibitors Fierce Biotech
William Rigel, Warren, Ohio - WKBN.com
William Rigel, Warren, Ohio WKBN.com
2024, April 25: Rigel Slips into Bright Evening Twilight - When the Curves Line Up
2024, April 25: Rigel Slips into Bright Evening Twilight When the Curves Line Up
Bad News for Berkeley Advocates: Rigel Robinson Resigns from City Council - Streetsblog San Franc...
Bad News for Berkeley Advocates: Rigel Robinson Resigns from City Council Streetsblog San Francisco
Rigel Pharmaceuticals: Undervalued FDA-Approved Products With Promising Cash Flow Potential - See...
Rigel Pharmaceuticals: Undervalued FDA-Approved Products With Promising Cash Flow Potential Seeking Alpha
Looking Up: Rigel marks Orion’s ‘left foot’ - The Columbus Dispatch
Looking Up: Rigel marks Orion’s ‘left foot’ The Columbus Dispatch
Rigel Pharmaceuticals Enters Collaboration and License Agreement with Kissei Pharmaceutical Co., ...
Pike's Strange New Worlds Mission Turned Star Trek's Rigel 7 Into A Tourist Trap - Screen Rant
Pike's Strange New Worlds Mission Turned Star Trek's Rigel 7 Into A Tourist Trap Screen Rant
Rigel Pharmaceuticals (RIGL) Stock Soars on FDA Approval News - InvestorPlace
Rigel Pharmaceuticals (RIGL) Stock Soars on FDA Approval News InvestorPlace
Meet Dr. Rigel Pinon-sloss - Bold Journey Magazine
Meet Dr. Rigel Pinon-sloss Bold Journey Magazine